AMSTERDAM, the Netherlands — For patients with unresectable intermediate-stage hepatocellular carcinoma, selective internal radioembolization and standard transarterial chemoembolization provide ...
Los Angeles, CA – September 3, 2025 - Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in ...
During the 98th Scientific Assembly and Annual Meeting of the Radiological Society of North America in Chicago from Nov. 25 to 30, GE Healthcare announced the receipt of U.S. Food and Drug ...
Overview of secondary liver cancer care pathways, key treatment steps, and the situations where dendritic cell treatment may be discussed as a selected option.
One expert said the results have the potential to change the standard of care for some patients with the most common type of liver cancer. Adding durvalumab and bevacizumab to a well-known therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results